Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt European Medicines Agency publishes first weekly pandemic pharmacovigilance update 3 december 2009Press releaseMedicines Axxonis Pharma AG withdraws its marketing authorisation application for Nenad (lisuride) 3 december 2009Press release Antigenics Therapeutics Limited withdraws its marketing authorisation application for Oncophage (vitespen) 2 december 2009Press release European Medicines Agency recommends authorisation of two additional Bluetongue vaccines through the centralised procedure 27 november 2009Press releaseMedicines Meeting highlights from the Paediatric Committee: 11 - 13 November 2009 24 november 2009Press releaseHumanPaediatrics European Medicines Agency reaffirms efficacy and safety of H1N1 pandemic vaccines 20 november 2009Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 16-19 November 2009 20 november 2009Press releaseHuman European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents 20 november 2009Press releaseMedicines Otsuka Pharmaceutical Europe Ltd withdraws its application for an extension of indication for Abilify (aripiprazole) 19 november 2009Press release Better surveillance needed to fight spread of antimicrobial resistance in zoonotic infections 16 november 2009Press release 1 … 293 294 295 296 297 Page 297 of 380 298 299 300 301 … 380
European Medicines Agency publishes first weekly pandemic pharmacovigilance update 3 december 2009Press releaseMedicines
Axxonis Pharma AG withdraws its marketing authorisation application for Nenad (lisuride) 3 december 2009Press release
Antigenics Therapeutics Limited withdraws its marketing authorisation application for Oncophage (vitespen) 2 december 2009Press release
European Medicines Agency recommends authorisation of two additional Bluetongue vaccines through the centralised procedure 27 november 2009Press releaseMedicines
Meeting highlights from the Paediatric Committee: 11 - 13 November 2009 24 november 2009Press releaseHumanPaediatrics
European Medicines Agency reaffirms efficacy and safety of H1N1 pandemic vaccines 20 november 2009Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 16-19 November 2009 20 november 2009Press releaseHuman
European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents 20 november 2009Press releaseMedicines
Otsuka Pharmaceutical Europe Ltd withdraws its application for an extension of indication for Abilify (aripiprazole) 19 november 2009Press release
Better surveillance needed to fight spread of antimicrobial resistance in zoonotic infections 16 november 2009Press release